Billings, compares the state’s purchase of overdose reversal drugs like Narcan from companies that have contributed to the ...

Hikma Pharmaceuticals PLC HIK shares advanced 1.97% to £21.72 Monday, on what proved to be an all-around positive trading ...

Shares of Hikma Pharmaceuticals PLC HIK inched down 0.75% to £21.30 Friday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index UKX falling 0.73% to ...

Hikma Pharmaceuticals (LON:HIK – Free Report) had its price objective lifted by Berenberg Bank from GBX 2,400 ($29.74) to GBX 2,560 ($31.73) in a research note published on Wednesday morning, ...

Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, today announces that it has entered an exclusive commercial partnership with Emergent BioSolutions (Emergent) for the ...

London – M42, a global health leader powered by artificial intelligence (AI), and Hikma Pharmaceuticals PLC (Hikma), ...

The introduction of the Shield™ test for colorectal cancer screening marks a transformative step in advancing precision and ...

Papa presented the company’s “turnaround plan” for 2025 at J.P. Morgan. “We are focused on first stabilising the company, then turning it around and ultimately transforming the company,” Papa told the ...

announced today that it has entered into an agreement to obtain exclusive commercial rights in the U.S. and Canada to Hikma Pharmaceuticals’ KLOXXADO ® (naloxone HCl) Nasal Spray, an 8 mg ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...